Neoplasia/BPH

	Percutaneous thermal ablation versus robot-assisted partial nephrectomy for localized renal cell carcinoma: a systematic review and meta-analysis stratified by tumor complexity. J Robot Surg Zorzi F, Amodeo A, Moretto S, Ingels A, Crestani A, Di Gianfrancesco L, Giannarini G, Tulone G, Simonato FA, Liguori G, Panthier F, Pandolfo SD, Contieri R, Perdonà S, Simonato A, Porreca A, Pavan N, Claps F. PMID: 42223755 [PubMed - indexed for MEDLINE]
	Sport, genetic susceptibility, and the risk of benign prostatic hyperplasia: a large prospective cohort study. World J Urol Zhao Z, Wu C, Fu S, Cheng C, Xiong Y, Yuan J, Wang X, Qin F. PMID: 42223661 [PubMed - indexed for MEDLINE]
	Renal and Extramedullary Involvement Revealing Atypical Multiple Myeloma: A Case Report and a Literature Review. Tunis Med El Ati Z, Hadhri A, Dahmane R, Ayed A, Hadj Brahim M, Boukadida R, Zouaghi K, Jaballah L, Raies L. PMID: 42223467 [PubMed - indexed for MEDLINE]
	Artificial intelligence-assisted urine cytology based on the Paris System for Reporting Urothelial Carcinoma. Cancer Cytopathol Chen L, Cao X, Lu Z, Liu L, Sun M, Wu Y, Zhang W. PMID: 42223163 [PubMed - indexed for MEDLINE]
	Perioperative Apalutamide in High-Risk Localized Prostate Cancer. N Engl J Med Taplin ME, Gleave M, Shore ND, Lopez-Gitlitz A, Kretschmer A, Efstathiou E, Nguyen PL, Damião R, Kamoto T, Ross A, Briganti A, Hadaschik BA, Heidenreich A, Juárez Soto Á, Ye H, Gotto G, Rooney B, Tian SK, Wetherhold L, Miladinovic B, McCarthy SA, Evans CP, Kibel AS, PROTEUS Investigators. PMID: 42223077 [PubMed - as supplied by publisher]
	PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer. N Engl J Med Agarwal N, Matsubara N, Azad AA, Saad F, Mateo J, Jiang S, Ye D, Voog E, Shore ND, Çil T, Vulsteke C, Chung HJ, Zschäbitz S, Laird AD, Zhang X, Nandoskar P, Chetcuti SF, Wang F, Fizazi K. PMID: 42223064 [PubMed - as supplied by publisher]
	Uncontrolled Hypertension Leading to the Diagnosis of Renal Cell Carcinoma: A Case Report. Cureus Loja J, Nascimento RF, Caldeira E, Moniz ME, Freitas JM. PMID: 42222619 [PubMed]
	Characteristics, treatment patterns, and outcomes of patients with metastatic prostate cancer during 2014-2022 in Pirkanmaa, Finland-an observational study. Ther Adv Urol Moisander M, Hölsä O, Teittinen K, Kysenius K, Kosunen M, Lehmus L, Murtola TJ. PMID: 42221687 [PubMed]
	[Expression of NF-ÎºB, EGFR, and HER3 in castration-resistant prostate adenocarcinoma: a clinical and molecular study of 88 Moroccan patients]. Pan Afr Med J Sadaoui I, Sadaoui I, Joutei HAH, Benomar H, Nadifi S. PMID: 42221598 [PubMed - indexed for MEDLINE]
	Radiological Presentations of Prostatic Carcinoma Patients: A Retrospective Observational Study From a Tertiary Care Oncology Setup. Cureus Altaf MO, Nasir K, Mughal Z, Niaz MM. PMID: 42220745 [PubMed]
	Efficacy and safety of immune checkpoint inhibitors combined with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: a risk-stratified systematic review and meta-analysis. Front Immunol Rao Y, Zhang J, Gu X, Han J, Ye Z. PMID: 42220544 [PubMed - indexed for MEDLINE]
	Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes. Front Immunol Chen ST, Zhou DR, Ge YJ, Chang L, Guo SH, Wu GS, Feng NH. PMID: 42220493 [PubMed - indexed for MEDLINE]
	Identification of succinylation-related genes in bladder cancer: integration of single-cell and transcriptomic data. Front Immunol Yang J, You Z, Mo H, Pu J, Shen G, Miao Z. PMID: 42220482 [PubMed - indexed for MEDLINE]
	Radiomics-Based Machine Learning versus the MAP Score for Predicting Haematocrit Decline after Laparoscopic Partial Nephrectomy. J Coll Physicians Surg Pak Dogan Y, Ozdes AA, Yildirim M, Beler M, Kartal D, Pirincci N. PMID: 42219835 [PubMed - indexed for MEDLINE]
	Investigating Setup Error Differences between Conventional and Ultra-Hypofractionated Whole Pelvis Radiation Therapy: A Secondary Analysis from the HOPE Randomized Clinical Trial. J Appl Clin Med Phys Schaly B, Mendez LC, Khawaja M, Black A, Warner A, Hoover DA. PMID: 42219614 [PubMed - indexed for MEDLINE]
	Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study. Cancer Res Commun Aggarwal RR, Italiano A, Domchek SM, Goodman O, Postel-Vinay S, García-Donás J, Dorff T, Reichert ZR, Vinceneux A, Shore N, Marshall CH, Armenia J, Parr G, Kmieciak A, Lukashchuk N, Murina O, Slade D, Shah N, Loembé B, Dean E, Sanai E, Abida W. PMID: 42219553 [PubMed - as supplied by publisher]
	Histotripsy-induced acute kidney injury following liver tumor treatment: A preliminary report of 9 cases. J Vasc Interv Radiol Poe LL, Kisting AL, Mendiratta-Lala M, Abi-Jaoudeh N, Breuer JA, Fidelman N, Raman SS, Lee FT Jr, Lokken RP, Caoili EM, Shah R, Hinshaw JL. PMID: 42218940 [PubMed - as supplied by publisher]
	Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK biobank. Brief Bioinform Lu J, Thygesen JH, Beaumont RN, Weedon MN, Green HD. PMID: 42218711 [PubMed - in process]
	Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients. Jpn J Clin Oncol Ichiyama T, Narita T, Sekine Y, Shinohara M, Kawashima Y, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 42218684 [PubMed - as supplied by publisher]
	Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial. J Clin Oncol Necchi A, de Jong JJ, Maiorano BA, Proudfoot JA, Basile G, Cigliola A, Mercinelli C, Tateo V, Piacentini M, Crupi E, Pastorino GL, Latini G, Tomasi E, Davicioni E, Moschini M, Brembilla G, Colecchia M, de Cobelli F, Ross JS, Madison R, Tambaoan CFB, Briganti A, Montorsi F. PMID: 42218654 [PubMed - as supplied by publisher]

Articles 1 - 20 / 188285

Page 1 of 9415



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy